$\require{mediawiki-texvc}$
  • 검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
  • 검색연산자
검색연산자 기능 검색시 예
() 우선순위가 가장 높은 연산자 예1) (나노 (기계 | machine))
공백 두 개의 검색어(식)을 모두 포함하고 있는 문서 검색 예1) (나노 기계)
예2) 나노 장영실
| 두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색 예1) (줄기세포 | 면역)
예2) 줄기세포 | 장영실
! NOT 이후에 있는 검색어가 포함된 문서는 제외 예1) (황금 !백금)
예2) !image
* 검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색 예) semi*
"" 따옴표 내의 구문과 완전히 일치하는 문서만 검색 예) "Transform and Quantization"
쳇봇 이모티콘
안녕하세요!
ScienceON 챗봇입니다.
궁금한 것은 저에게 물어봐주세요.

논문 상세정보

Abstract

We have shown that long-term intake of Korean red ginseng (KRG) delays disease progression in HIV-I infected patients. In the present study to investigate whether this slow progression was associated with protective human leukocyte antigen (HLA) alleles as well as with KRG-intake, we have performed clinical analysis of 31 HIV-1 infected patients who have been living for more than 10 years without any antiretroviral therapy. Average amount of KRG-intake over $130\;{\pm}16$ months was $4,797\;{\pm}4,921\;g$ and the annual decrease in CD4 T cell (AD) was $30\;{\pm}29{\mu}L$. We observed significant correlations among amount of KRG-intake, AD(r=-0.53, P < 0.01), and plasma HIV-1 RNA copy (r=-0.35, P < 0.05), along with a significant correlation between KRG-intake and HLA score AD(r=-0.49, P < 0.01), whereas there was no significant correlation between HLA score and AD or viral load. When the 31 patients were divided into 2 groups based on the amount of KRG-intake, the $AD(14/{\mu}L)$ in the 16 patients who had taken higher amounts of KRG was significantly less than that $(49/{\mu}L)$ in the 15 patients with a little or no KRG-intake (P < 0.01). These data indicate that KRG-intake sig­nificantly slows CD4 T cell depletion in HIV-1 infected patients.

참고문헌 (39)

  1. Ho. D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M. and Markowitz, M. : Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 373, 123-126 (1995) 
  2. Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A. Hahn, B. H., Saag, M. S. and Shaw, G. M. : Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 373, 117-122 (1995) 
  3. Chun, T. W., Stuyver, L., Mizell, S. B., Ehler, L. A., Mican, J. A., Baseler, M. and Fauci, A. S. : Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci USA. 94, 13193-13197 (1997) 
  4. Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, K., Chadwick, K., Margolick, J., Brookmeyer, R., Gallant, J., Markowitz, M., Ho, D. D., Richman, D. D. and Siliciano, R. F. : Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 278, 1295-1300 (1997) 
  5. Wong, J. K., Hezareh, M., Gunthard, H. F., Havlir, D. V., Ignacio, C. C., Spina, C. A. and Richman, D. D. : Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 278. 1291-1295 (1997) 
  6. Chun, T. W., Engel, D., Mizell, S. B., Ehler, L. A. and Fauci, A. S. : Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines. J Exp Med. 188, 83-91 (1998) 
  7. Chun, T. W., Engel, D., Mizell, S. B., Hallahan, C. W., Fichette, M., Park, S., Davey Jr., R. T., Dybul, M., Kovacs, J. A., Metcalf, J. A., Mican, J. M., Berrey, M. M., Corey, M., Lane, H. C. and Fauci, A. S. : Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy. Nat Med. 5, 651-655 (1999) 
  8. Li, C. P. and Li, R. C. : An introductory note to ginseng. Am J. Chinese Med. 1, 249-261 (1973) 
  9. O'Hara, M. A., Kiefer, D., Farrell, K. and Kemper, K. : A review of 12 commonly used medicinal herbs. Arch Fam Med. 7, 523-536 (1998) 
  10. Singh, V. K. and Agarwhal, S. S. and Gupta, B. M. : Immunomodulatory activity of Panax ginseng extract. Planta Med. 50, 462-465 (1984) 
  11. Scaglione, F., Ferrara, F., Dugnani, S., Falchi, M., Santoro, G. and Fraschini, F. : Immunomodulatory effects of two extracts of Panax ginseng C. A. Meyer. Drugs Exp Clin Res. 16, 537-542 (1990) 
  12. See, D. M., Broumand, N., Sahl, L. and Tilles, J. G. : In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunopharmacology. 35, 229-235 (1997) 
  13. Kim, K .H., Lee, Y. S., Jung, I. S., Park, S. Y., Chung, H. Y., Lee, I. R. and Yun, Y. S. : Ac idis polysaccharide from Panax ginseng, ginsan, induces Th1 cell and macrophage cytokines and generates LAK cells in synergy with rIL-2. Planta Med. 64, 110-115 (1998) 
  14. Lee, Y. S., Chung, I. S., Lee, I. R., Kim, K. H., Hong, W. S. and Yun, Y. S. : Activation of multiple effector pathway of immune system by the antineoplastic immunostimulator acidic polysaccharide ginsan isolated from Panax ginseng. Anticancer Res. 17, 323-231 (1997) 
  15. Lam, S. K. and Ng, T. B. : A xylanase from roots of sanchi ginseng (Panax notoginseng) with inhibitory effects on human immunodeficiency virus-1 reverse transcriptase. Life Sci. 70, 3049-3058 (2002) 
  16. Cho, Y. K., Kim, Y. K., Lee, I., Choi, M. H. and Shin, Y. O. : The effect of Korean red ginseng (KRG), zidovudine (ZDV), and the combination of KRG and ZDV on HIV-infected patients. J Kor Soc Microbiol. 31, 353-360 (1996) 
  17. Cho, Y. K., Lee, H. J., Kim, Y. B., Oh, W. I. and Kim, Y. K. :Sequence analysis of C2/V3 region of human immunodeficiency virus type 1 gp120 and its correlation with clinical significance; the effect of long-term intake of Korean red ginseng on env gene variation. J Kor Soc Microbiol. 32, 611-623 (1997) 
  18. Cho, Y. K., Sung, H., Lee, H. J., Joo, C. H. and Cho, G.. J. : Long-term intake of Korean red ginseng in HIV-1-infected patients: development of resistance mutaiton to zidovudine is delayed. Int Immunopharmacol. 1, 1295-1305 (2001) 
  19. Cho, Y. K., Sung, H., Ahn, S. H., Bae, I. G., Woo, J. H., Won, Y. H., Kim, D. G. and Kang, M. W. :Frequency of mutations conferring resistance to nucleoside reverse transcriptase inhibitors in human immunodeficiency virus type-1 infected patients in Korea. J Clin Microbiol. 40, 1319-1325 (2002) 
  20. Kaslow, R. A., Carrington, M., Apple, R., Park, L., Munoz, A., Saah, A. J., Goedert, J. J., Winkler, C., O'Brien, S. J., Rinaldo, C., Detels, R., Blattner, W., Phair, J., Erlich, H. and Mann, D. L. : Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med. 2, 405-411 (1996) 
  21. Kroner B. L., Goedert, J. J., Blattner, W. A., Wilson, S. E., Carrington, M. N. and Mann, D. L. : Concordance of human leukocyte antigen haplotype-sharing, CD4 decline and AIDS in hemophilic siblings. Multicenter Hemophilia Cohort and Hemophilia Growth and Development Studies. AIDS. 9, 275-280 (1995) 
  22. Kaslow, R. A. and Mann, D. L. : The role of the major his-tocompatibility complex in human immunodeficiency virus infection-ever more complex? J Infect Dis. 169, 1332-1333 (1994) 
  23. Just, J. J. : Genetic predisposition to HIV-1 infection and acquired immune deficiency virus syndrome: a review of the literatur examining associations with HLA. Hum Immunol. 44, 156-169 (1995) 
  24. Mann, D. L. : HLA and HIV-1 infection. p.155-171, In: Dal-gleish, A.G., Weiss, R. A. (ed), HIV and the new viruses. Academic Press, London (1999) 
  25. Krausa, P., Browning, M. J., Moses, J. H. and Bodmer, J. G. : HLA-A locus DNA typing of the 4AOH cell panel by by arms PCR. Eur Immunogenet. 21, 199-204 (1994) 
  26. Sadler, A. M., Petronzelli, F., Krausa, P., Marsh, S. G., Gut-tridge, M. G., Browning, M. J. and Bodmer, J. G. : Low-res-olution DNA typing for HLA-B using sequence-specific primers in allele- or group-specific ARMS/PCR. Tissue Anti-gens. 44, 148-154 (1994) 
  27. Bunce, M. and Welsh, K. I. : Rapid DNA typing for HLA-C using sequence-specific primers (PCR-SSP): identification of serological and non-serologically defined HLA-C alleles including several new alleles. Tissue Antigens. 43, 7-17 (1994) 
  28. Carrington, M., Colonna, M., Spies, T., Stephens, J. C. and Mann, D. L. : Haplotypic variation of the transporter associated with antigen processing (TAP) genes and their extension of HLA class II region haplotypes. Immunogenetics. 37, 266-273 (1993) 
  29. Saah, A. J., Hoover, D. R., Weng, S., Carrington, M., Mellors, J., Rinaldo Jr., C. R., Mann, D., Apple, R., Phair, J. P., Detels, R., O'Bruebm S,, Enger, C., Johnson, P. and Kaslow, R. A. : Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV-1 infection. Multicenter AIDS Cohort Study. AIDS. 12, 2107-2113 (1998) 
  30. Hendel, H., Caillat-Zucman, S., Lebuanec, H., Carrington, M., O'Brien, S., Andrieu, J. M., Schachter, F., Zagury, D., Rappaport, J., Winkler, C., Nelson, G. W. and Zagury, J.F. : New class I and Il HLA alleles strongly associated with opposite patterns of progression to AIDS. J Infect Dis. 162, 6942-6946 (1999) 
  31. Cho, Y. K., Choi, B. S., Kim, Y. B., Cho, G.. J., Kang, C., Kim, S. S., Kee, M. K., Hur, S. J., Kim, T. S., Cho, Y. J. and Shin, Y. O. : CD+4 T lymphocyte, beta-microglobulin and p24 antigen level in HIV infected persons. Korean J of Infectious Diseases. 25, 139-149 (1993) 
  32. Kestler 3rd, H. W., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D. and Desrosiers, R. C. : Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell. 65, 651-662 (1991) 
  33. Rhodes, D. I., Ashton, L., Solomon, A., Carr. A., Cooper, D., Kaldor, J. and Deacon, N. : Characterization of three nef-defective human immunodeficiecy virus type 1 strains associated with long-term nonprogression. Australian Long-Term Nonprogressor Study Group. J Virol. 74, 10581-10588 (2000) 
  34. Ammaranond, P., Guerin, J., Anderson, B., Doong, N.C., Fin-layson, R., Kelly, M., McMurchie, M., Price, R., Cooper, D. A., Kelleher, A. D. and LTNP study group. : The effect of escape mutation upon disease progression in HLA B27 posi-tive individuals within the Australian long-term non progres-sor cohort. Abstract no. MoPeC3397, p.99. XV international AIDS conference in Bangkok, Thailand (2004) 
  35. Cho, Y. K., Lee, K., Koh, H., Lee, H., Lim, J. and Jung, Y. : Effects of Korean red ginseng on high frequency of gross deletion in the nef gene and progression rate, Abstract no. 139, p111. Keystone symposia, Molecular mechanisms of HIV pathogenesis (X7) in Whistler, Canada (2004) 
  36. Haynes, B. F., Pantaleo, G. and Fauci, A. S. : Toward an understanding of the correlates of protective immunity to HIV infection. Science. 271, 324-328 (1996) 
  37. Cho, Y. K., Lee, H. J., Oh, W. I. and Kim, Y. K. : Long-term immunological effect of ginseng on HIV-infected patients. Abstract no. E-44, p247. 97th ASM General Meeting in Florida, USA (1997) 
  38. Nocerino, E., Amato, M. and Izzo, A. A. : The aphrodisiac and adaptogenic properties of ginseng. Fitoterapia. 71, Suppl 1, S1-S5 (2000) 
  39. Silvestri, G., Sodora, D. L., Koup, R.A., Paiardini, M., O'Neil, S. P., McClure, H.M., Staprans, S. I. and Feinberg, M. B. : Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity. 18, 441-452 (2003) 

이 논문을 인용한 문헌 (3)

  1. 2010. "" Journal of applied biological chemistry, 53(4): 202~206 
  2. 2010. "" Journal of ginseng research = 高麗人參學會誌, 34(3): 219~226 
  3. 2011. "" Journal of ginseng research = 高麗人參學會誌, 35(4): 413~420 

DOI 인용 스타일